HOF Capital is a venture capital fund specializing in early-stage biotech and health tech companies. They support founders from the initial idea through to becoming public companies, backed by over 200 industry leaders. Notable investments include Cambrium. HOF Capital aims to help entrepreneurs create enduring companies with a long-term investment strategy.